Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.48 |
| ▸ | FABP1 | P07148 | 1/20 | 0.47 |
| ▸ | FABP6 | P51161 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | UBE2N | P61088 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GALR3 | O60755 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4590092 | 0.78 | FABP1 (0.52) | KCNH3FABP1FABP6KMT2AKDM5B | |
| SCHEMBL28931524 | 0.77 | GAA (0.56) | KCNH3KMT2ALMNAGAAMEN1 | |
| SCHEMBL3298289 | 0.77 | KCNH3 (0.73) | KCNH3RAD52KMT2APOLBLMNA | |
| SCHEMBL23989829 | 0.75 | MAPT (0.53) | KMT2APOLBLMNAGAAMEN1 | |
| SCHEMBL9779691 | 0.74 | FABP1 (0.52) | KCNH3FABP1FABP6KMT2ALMNA | |
| SCHEMBL1413125 | 0.73 | FABP1 (0.67) | FABP1FABP6KMT2AMEN1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28584936 | 0.72 | KCNH3 (0.52) | KCNH3FABP1FABP6KMT2ALMNA | |
| SCHEMBL28475529 | 0.71 | FABP1 (0.64) | FABP1FABP6KMT2AMEN1ALDH1A1 | |
| SCHEMBL15900559 | 0.69 | FABP1 (0.61) | FABP1FABP6KMT2AKDM5BLMNA | |
| SCHEMBL1924100 | 0.69 | HTT (0.78) | KMT2AGAAMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119896633-A | Hydrogel cold compress and cold and hot compress set prepared from hydrogel cold compress and application of hydrogel cold compress | 中国人民解放军空军军医大学 | 2025-04-29 | — | — | CN | claimed |
| US-11786600-B2 | Cliptac composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-10-17 | — | — | US | claimed |
| CN-112126081-B | Fast-curable hydrogel based on inverse Diels-Alder reaction, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-01-31 | — | — | CN | claimed |
| CN-112126069-B | Rapidly curable hydrogel based on collagen and hyaluronic acid, preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2021-12-21 | — | — | CN | claimed |
| CN-112126081-A | Fast-curable hydrogel based on inverse Diels-Alder reaction, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2020-12-25 | — | — | CN | claimed |
| CN-112126069-A | Rapidly curable hydrogel based on collagen and hyaluronic acid, preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2020-12-25 | — | — | CN | claimed |
| US-20190275161-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-09-12 | — | — | US | claimed |
| WO-2017212329-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-12-14 | — | — | WO | claimed |
| CN-102271712-B | For by substance delivery to the compositions of biological target and method | THE GENERAL HOSPITAL CORP. (US) | 2015-11-25 | — | — | CN | claimed |
| EP-3474901-B1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | TAGWORKS PHARMACEUTICALS B V (NL) | 2025-08-06 | — | — | EP | disclosed |
| CN-119896633-A | Hydrogel cold compress and cold and hot compress set prepared from hydrogel cold compress and application of hydrogel cold compress | 中国人民解放军空军军医大学 | 2025-04-29 | — | — | CN | disclosed |
| US-12186405-B2 | Cleavable tetrazine used in bio-orthogonal drug activation | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2025-01-07 | — | — | US | disclosed |
| US-12161734-B2 | Multimodal silica-based nanoparticles | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240131169-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| US-20110268654-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | THE GENERAL HOSPITAL CORPORATION (US) | 2011-11-03 | — | — | US | disclosed |
| WO-2011112970-A2 | COMPOSITIONS AND METHODS FOR BIOCONJUGATION TO QUANTUM DOTS | THE GENERAL HOSPITAL CORPORATION (US) | 2011-09-15 | — | — | WO | disclosed |
| EP-2361098-A2 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | The General Hospital Corporation (US) | 2011-08-31 | — | — | EP | disclosed |
| WO-2010119389-A2 | PRETARGETING KIT, METHOD AND AGENTS USED THEREIN | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010119382-A1 | PRETARGETING KIT, METHOD AND AGENTS USED THEREIN | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010051530-A2 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | THE GENERAL HOSPITAL CORPORATION (US) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268654-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | FCER2, EPCAM, EPHA2 | KCNH3 4694/4885FABP1 199/4885FABP6 1493/4885 |
| US-11786600-B2 | Cliptac composition | UBE3C, CBLC, STUB1 | KCNH3 4810/4885FABP1 1359/4885FABP6 2445/4885 |
| US-20190275161-A1 | CLIPTAC COMPOSITION | UBE3C, CBLC, STUB1 | KCNH3 4810/4885FABP1 1359/4885FABP6 2445/4885 |
| US-20240131169-A1 | CLIPTAC COMPOSITION | UBE3C, CBLC, STUB1 | KCNH3 4810/4885FABP1 1359/4885FABP6 2445/4885 |
| US-12186405-B2 | Cleavable tetrazine used in bio-orthogonal drug activation | KIT, TPSB2, BTD | KCNH3 3247/4885FABP1 3309/4885FABP6 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.